In this regard, the previously studied A-T mouse model harboring a different targeted ATM allele exhibited a significantly earlier onset of lymphoid tumors and shorter mean survival compared to our ATM-deficient mouse model44,46. This evidence concerns the gene ATM and lymphoid neoplasm.